NEW YORK (GenomeWeb) – ReadCoor announced today that it has partnered with the Joint Pathology Center (JPC) to develop diagnostic tools for determining the pathogenic cause of mortality using its proprietary FISSEQ (Florescent In-Situ Sequencing) technology.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.